Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid Phenyl Ester SCHEMBL4873074 | 0.91 | PARP10 (0.37) | PARP10CTNNB1KMT2AMEN1CA4 | |
| Formic Acid Phenyl Ester SCHEMBL4878385 | 0.86 | CTNNB1 (0.36) | PARP10CTNNB1KMT2AALDH1A1GAA | |
| Formic Acid Phenyl Ester SCHEMBL28117692 | 0.81 | ALDH1A1 (0.42) | PARP10THRBTGM2CTNNB1KMT2A | |
| Formic Acid Phenyl Ester SCHEMBL28122237 | 0.80 | THRB (0.41) | PARP10THRBTGM2CTNNB1KMT2A | |
| Formic Acid Phenyl Ester SCHEMBL27930651 | 0.78 | TSHR (0.41) | PARP10KMT2ACA4ALDH1A1GAA | |
| Formic Acid Phenyl Ester SCHEMBL27835860 | 0.78 | CA4 (0.43) | KMT2ACA4ALDH1A1GAAMAOB | |
| Formic Acid Phenyl Ester SCHEMBL2662 | 0.78 | — | — | |
| Formic Acid Phenyl Ester SCHEMBL27326128 | 0.78 | LTA4H (0.45) | THRBKMT2AMEN1CA4ALDH1A1 | |
| Formic Acid Phenyl Ester SCHEMBL30093829 | 0.77 | MTNR1A (0.40) | KMT2ACA4ALDH1A1GAAMAPT | |
| Formic Acid Phenyl Ester SCHEMBL28738736 | 0.77 | CA4 (0.44) | KMT2ACA4ALDH1A1GAAAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8376142-B2 | Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies | CYTEC TECHNOLOGY CORP. (US) | 2013-02-19 | — | — | US | claimed |
| EP-2117718-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008097707-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. (US) | 2008-08-14 | — | — | WO | claimed |
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. | 2008-08-07 | — | — | US | claimed |
| EP-2117718-B1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECH CORP (US) | 2017-05-10 | — | — | EP | disclosed |
| CN-103433145-B | Use the method for the beneficiation of mineral ore bodies of dithiocarbamate collector | CYTEC TECH CORP (US) | 2015-08-12 | — | — | CN | disclosed |
| US-8376142-B2 | Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies | CYTEC TECHNOLOGY CORP. (US) | 2013-02-19 | — | — | US | disclosed |
| EP-2117718-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. (US) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008097707-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. (US) | 2008-08-14 | — | — | WO | disclosed |
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | FTH1, FECH, SLC40A1 | PARP10 4777/4885THRB 1166/4885TGM2 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.